| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
agilon health, inc.$107.85
+15.22 (+16.06%)
Market Cap
1.80 B
EPS
-21.25
P/E Ratio
-
Value Trade
21.11 M
SEC Financials
Q1 2026Dilution Risk
Revenue
1.42 B
Operating CF
23.73 M
Total Assets
1.50 B
Total Liabilities
1.32 B
Equity
181.43 M
16.39 %
Week
0.23 %
1 Month
287.25 %
3 Month
525.85 %
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
231.41 M
Monthly Burn
-
Runway
-
Burn Trend
SEC Filing
May 6, 2026
Overview
Volume
1.11 M
52 Week Range
7.48 - 133.04
% held by Insiders
29.79 %
% held by Institutions
68.33 %
Enterprise Value
1.60 B
Total Shares
16.69 M
Short %
7.34 %
Float Shares
12.24 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in AGL
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
AGL Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2027-01-15 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2027-01-15 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2027-01-15 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-AGL
Aug 5, 2026▲ +16.1%today
agilon health Reports Second Quarter 2026 Results
Agilon Health, Inc. reported strong second quarter results for 2026, surpassing expectations. The company also raised its full-year guidance for total revenues, medical margin, and Adjusted EBITDA. This performance highlights the effectiveness of Agilon's strategic initiatives and boosts confidence in future growth.
Read more →-AGL
Jul 10, 2026agilon health Reports ACO REACH Model Results for 2024 Performance Year
Agilon Health reported significant financial results for its ACOs under the ACO REACH model for the 2024 performance year. The company achieved $229 million in gross savings, translating to a 13.6% savings rate, with $54 million benefiting the Medicare Trust Fund. This performance highlights the effectiveness of agilon's approach in managing healthcare costs.
Read more →-AGL
Jul 7, 2026agilon health Sets Date to Report Second Quarter 2026 Financial Results
Agilon Health has announced the date for its second quarter 2026 financial results report. The specific details regarding the report's content or any anticipated highlights were not provided in the announcement.
Read more →-AGL
Jun 9, 2026▲ +7.2%on this news· ran to +18% by day 3
agilon health to Participate in Upcoming Conferences
Agilon Health is set to participate in upcoming conferences, showcasing its commitment to engaging with stakeholders. The article highlights the company's proactive approach in the healthcare sector. Details about the specific conferences or topics of discussion were not provided.
Read more →-AGL
May 6, 2026agilon health Reports First Quarter 2026 Results
Agilon Health has reported its financial results for the first quarter of 2026. The article provides limited details regarding the performance metrics or any significant developments during this period. Further insights into the company's operations or future outlook are not provided.
Read more →-AGL
May 6, 2026agilon health Reports First Quarter 2026 Results Raises Full-Year 2026 Total Revenues, Medical Margin and Adjusted EBITDA Guidance Westerville, O.H.
Agilon Health reported its first-quarter results for 2026, showcasing a 162% increase in Adjusted EBITDA and positive short-term guidance for total revenues and medical margins. The company saw some challenges, including an 11% drop in total members, impacted by strategic market exits. Leadership changes, including the appointment of a new CEO, signal a focus on operational enhancement. Despite a decrease in year-over-year revenue, the firm expressed confidence in its long-term growth trajectory.
Read more →-AGL
Apr 27, 2026agilon health Appoints Tim O’Rourke as Chief Executive Officer
Agilon Health has appointed Tim O’Rourke as the new Chief Executive Officer. This leadership change is expected to impact the company's strategic direction. Further details about O'Rourke's background and plans for the company have not been disclosed in the article.
Read more →-AGL
Apr 27, 2026practice. His commitment to supporting the people who deliver care every day gives me great confidence that agilon is entering its next chapter with the right leader at the helm." "agilon has built a distinct platform th
Agilon Health has announced the appointment of Tim O'Rourke as its new Chief Executive Officer, effective May 7, 2026, following a comprehensive search. O'Rourke succeeds Ronald A. Williams, who will remain as Chairman of the Board. With over 25 years in healthcare leadership, O'Rourke aims to build on agilon's recent operational and financial improvements, focusing on delivering value-based care. He expresses confidence in supporting the company's physician partners to achieve sustainable health care outcomes.
Read more →-AGL
Apr 6, 2026▲ +30%on this news· ran to +85% by day 3
agilon health Sets Date to Report First Quarter 2026 Financial Results
Agilon Health has announced the date for reporting its financial results for the first quarter of 2026. The specific date has not been detailed in the article. This announcement is part of the company's regular financial reporting schedule.
Read more →-AGL
Mar 18, 2026agilon health Announces Reverse Stock Split
Agilon Health, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-25, effective March 30, 2026. This decision follows the approval by stockholders at a special meeting and is aimed at increasing the stock price above $1.00 to comply with NYSE requirements. The split is expected to enhance marketability and attract a broader range of investors, while the company's stock will trade on a split-adjusted basis beginning March 31, 2026.
Read more →-AGL
Feb 25, 2026▲ +26.9%on this news· ran to +56% by day 3
agilon health Reports Fourth Quarter and Full Year Fiscal 2025 Results Issues 2026 Guidance Highlighting Expected Breakeven Adjusted EBITDA Midpoint Westerville, O.H.
Agilon Health has released its fourth quarter and full year results for fiscal 2025, indicating both challenges and expectations for future improvement. The company experienced a slight revenue increase in Q4 2025, but overall annual revenue declined compared to the previous year. Significant losses were reported, with a net loss that nearly doubled year-over-year, although there is optimism regarding a possible recovery in 2026. Agilon's guidance includes expectations for breakeven Adjusted EBITDA, reflecting strategic transformation efforts underway.
Read more →-AGL
Jan 12, 2026Value-Based Care: A Better Way Forward for Patients and Physicians
The article discusses the importance of value-based care (VBC) in healthcare, emphasizing its focus on rewarding better patient outcomes rather than the number of services provided. Agilon Health partners with primary care physicians to implement VBC, particularly for senior patients, addressing the urgent need for coordinated care as the population ages. The model aims to reduce costs and improve wellness through preventive measures.
Read more →-AGL
Nov 7, 2025Document agilon Announces Receipt of Notice of Non-Compliance with the NYSE Continued Listing Standards To regain compliance agilon intends to seek shareholder approval for a reverse stock split Westerville, Ohio
Agilon Health, Inc. received a notice from the NYSE informing it of non-compliance with continued listing standards due to its common stock price falling below $1.00 per share for 30 consecutive trading days. To regain compliance, the company intends to seek shareholder approval for a reverse stock split at its annual meeting in 2026. While this notice does not immediately affect the stock's NYSE listing or business operations, it highlights financial challenges as the company moves to address these issues. The management is committed to informing the NYSE of their intention to remain listed by November 19, 2025.
Read more →-AGL
Nov 4, 2025▼ -10.6%on this newsshared move
agilon health Reports Third Quarter 2025 Results and Re-Establishes Full Year Outlook Continued Progress on Transformation Initiatives Including the Execution of $30 million in 2026 Operating Cost Reductions Westerville,
Agilon Health (AGL) has reported its third-quarter results for 2025, highlighting efforts toward transformation initiatives aimed at financial improvement. The company anticipates $30 million in operating cost reductions for 2026, associated with improved financial discipline and data visibility. However, the third quarter showed a decrease in total members and a net loss of $110 million, despite a minor reduction in adjusted EBITDA losses. Agilon has re-established its full-year outlook amidst these financial challenges.
Read more →-AGL
Oct 14, 2025▲ +5.3%on this news· ran to +18% by day 1
Heart Failure: Tapping the Full Potential of Our Total Care Model
Agilon Health is enhancing care for heart failure patients through its Total Care Model, focusing on early diagnosis and intervention. The integrated clinical pathways aim to reduce hospitalizations and improve treatment adherence among seniors. Early results show a significant decrease in inpatient diagnoses and improved medication management, leading to better patient outcomes.
Read more →-AGL
Sep 15, 2025The Benefits of Value-Based Care for Hispanic Seniors: A Primary Care Physician Shares How She Serves Her Community
Dr. Jesenia Cruz, a primary care physician in Buffalo, NY, emphasizes the importance of value-based care for Hispanic seniors. Her background allows her to communicate effectively with patients, addressing chronic health issues while respecting cultural dietary preferences. The partnership with agilon health enhances care coordination, leading to improved patient outcomes and experiences.
Read more →-AGL
Aug 4, 2025▲ +6.8%on this news· ran to -49% by day 3
agilon health Reports Second Quarter 2025 Results Total revenues of $1.4 billion in the second quarter 2025 Medicare Advantage membership of 498,000, and total members on the agilon platform of 614,000 as of
Agilon Health reported a total revenue of $1.4 billion for the second quarter of 2025, alongside a Medicare Advantage membership of 498,000. The company experienced a leadership change, with the suspension of full-year earnings guidance due to ongoing market dynamics and the need for operational optimization. Financially, agilon faced challenges, reporting a net loss of $104 million and a 6% decrease in revenue compared to the previous year. Despite these setbacks, agilon is committed to enhancing its strategic initiatives for future growth.
Read more →-AGL
Jun 23, 2025New Study Finds Senior Patients Managed by Women Physicians in a Value-Based Care (VBC) Model Have Equal or Better Clinical and Quality Outcomes and Less Healthcare Utilization
A new study published in JAMA Health Forum reveals that senior patients managed by women primary care physicians (PCPs) in a value-based care model experience equal or better clinical outcomes and lower healthcare utilization compared to those managed by men. The research analyzed nearly 900 PCPs and 225,000 Medicare Advantage patients across multiple states, indicating that women PCPs provide higher quality care while earning more per patient.
Read more →-AGL
Jun 9, 2025▲ +5.6%on this news
New Research Underscores the Important Role of Value-Based Care (VBC) in Improving Primary Care Access for Traditional Medicare Patients
Agilon Health's recent research highlights the effectiveness of value-based care (VBC) in improving primary care access for Traditional Medicare patients. The study found that PCPs who transitioned to VBC experienced a significant increase in new patient volume and extended availability for new patients. This model supports a more comprehensive approach to care, addressing the challenges faced by senior patients in accessing primary care.
Read more →-AGL
May 6, 2025▲ +8.3%on this news· ran to -30% by day 3
agilon health Reports First Quarter 2025 Results Total revenues of $1.53 billion in the first quarter 2025 Medicare Advantage membership of 491,000, and total members on the agilon platform of 605,000 as of
agilon health reported its financial results for the first quarter of 2025, with total revenues of $1.53 billion, seeing a decrease of 4% from the previous year. The company has a Medicare Advantage membership of 491,000, with a total of 605,000 members on its platform. Despite showing a net income of $12 million, a significant improvement from a loss in the previous year, overall membership declined due to market exits. The company aims to drive growth through strategic investments in technology and clinical programs.
Read more →-AGL
Apr 25, 2025How agilon health Reimagines Patient Experience by Transforming the Physician Experience
Agilon Health emphasizes the importance of physician experience in enhancing patient care. By prioritizing physician support and reducing administrative burdens, the company aims to foster better relationships between physicians and patients. Recent survey results show high satisfaction rates among Medicare beneficiaries, indicating the effectiveness of their value-based care model.
Read more →-AGL
Feb 25, 2025agilon health Reports Fourth Quarter and Full Year Fiscal 2024 Results Revenue increased 44% to $1.52 billion in the fourth quarter 2024 Medicare Advantage membership increased 36% to 527,000, and total members on the ag
Agilon Health reported strong financial results for the fourth quarter and full year of 2024, with revenue rising to $1.52 billion, a 44% increase from the previous year. Medicare Advantage membership also saw significant growth, reaching 527,000, which reflects a 36% year-over-year increase. Despite these positive metrics, the company experienced a negative gross profit and an adjusted EBITDA loss, indicating ongoing challenges in profitability. Looking ahead, Agilon anticipates continued elevated medical cost trends and has provided guidance for fiscal year 2025 that reflects these factors.
Read more →-AGL
Feb 20, 2025The VBC Advantage in Medicare Advantage
The article discusses the importance of Medicare Advantage (MA) and value-based care for primary care physicians. It highlights how MA can improve care quality and manage costs effectively. The proposed CY2026 rates from CMS aim to better reflect rising costs, which could stabilize MA plans and support primary care providers. However, concerns remain about payment misalignments affecting the sustainability of primary care.
Read more →-AGL
Nov 19, 2024investorpresen
Agilon Health recently presented its forward-looking statements in an investor presentation, focusing on business growth opportunities and financial expectations amidst macroeconomic challenges. The company aims to enhance profitability and execution while addressing the increasing healthcare demands of a growing senior population. Despite the optimistic outlook for long-term growth, Agilon Health remains cautious about risks, including historical net losses and challenges in expanding its partnerships and geographical reach. The presentation emphasized the importance of adapting to dynamic market conditions and the firm's commitment to long-term success.
Read more →-AGL
Nov 18, 2024REACHing for a Full-Risk Future: Why ACO REACH and Medicare Innovation Matter
The ACO REACH model, a pilot program under CMMI, reported significant savings and high-quality scores for participating ACOs in 2023. Agilon Health's ACOs contributed to a total of $694.6 million in net savings to Medicare. However, the program is temporary and faces uncertainty as it is set to end in 2026 without a permanent alternative.
Read more →-AGL
Nov 12, 2024▼ -13.4%on this news· ran to -27% by day 3
agilon health Reports ACO REACH Model Results for 2023 Performance Year
Agilon Health reported significant success in the 2023 performance year of the ACO REACH model, achieving $150 million in gross savings, including $37 million for the Medicare Trust Fund. The company's eight REACH ACOs provided care for around 90,000 Traditional Medicare beneficiaries, boasting an impressive average quality score of 95%. This model supports primary care physicians in delivering high-quality, cost-effective care.
Read more →-AGL
Nov 7, 2024agilon health Reports Third Quarter 2024 Results Revenue increased 28% to $1.45 billion, Medicare Advantage membership increased 37% to 525,000, and total members on the agilon platform grew 39% to 657,000 Third quarter
Agilon Health reported its third quarter results for 2024, revealing significant revenue growth of 28% to $1.45 billion, bolstered by an increase in Medicare Advantage membership by 37%. Despite the positive membership trends, the company faced substantial losses, with net losses rising to $118 million and gross profit falling into negative territory. The company is taking proactive measures to mitigate challenges in the Medicare Advantage landscape, planning to exit unprofitable partnerships to strengthen its business moving forward. Adjusted guidance for the year reflects ongoing efforts to navigate the prevailing medical expense pressures.
Read more →-AGL
Oct 2, 2024Q&A with Dr. Douglas Fullington: The Unmatched Power of Person-to-Person Care
Dr. Douglas Fullington discusses the transformative impact of the agilon health model on primary care. He highlights how this model enhances patient-physician relationships by allowing more time for meaningful interactions. Fullington also emphasizes the importance of data-driven care in improving health outcomes and reducing physician burnout. He encourages other physicians to consider joining the agilon network for better patient management.
Read more →-AGL
Sep 4, 2024▲ +8.3%on this news
Q&A with Dr. Kimberly Hudson: The Power of Data and Collaboration to Improve Primary Care
Dr. Kimberly Hudson discusses the transformative impact of agilon health's data-centric model on primary care. By utilizing data visibility and collaborative practices, her clinic has improved patient care and operational efficiency. The model allows for a holistic view of patient health, enhancing risk stratification and proactive management. Hudson emphasizes the rewarding nature of focusing on patient health and collaboration within the agilon network.
Read more →-AGL
Aug 6, 2024agilon health Reports Second Quarter 2024 Results Revenue increased 39% to $1.5 billion, Medicare Advantage membership increased 38% to 513,000, and total members on the agilon platform grew 40% to 645,000 Executing targ
Agilon Health reported a 39% year-over-year revenue increase for Q2 2024, reaching $1.5 billion, with significant growth in Medicare Advantage membership and total members. Management is maintaining its medical margin and Adjusted EBITDA guidance for the year despite a net loss of $31 million attributed to contract terminations and reduced gross profit. The company is actively implementing a performance action plan to boost profitability and improve its value proposition to physicians and payers.
Read more →-AGL
Aug 1, 2024Q&A with Dr. John Gover: Redefining Success After 38 Years
Dr. John Gover reflects on his nearly four-decade career in medicine and his transition to value-based care with agilon health. He discusses the challenges of adapting to change but highlights the positive outcomes of collaboration and redefining success in patient care. Gover believes that the new generation of physicians will benefit from a system that prioritizes quality over volume.
Read more →-AGL
Jul 10, 2024agilon health Appoints Karthik Rao, M.D., as Chief Medical Officer
Agilon Health has officially appointed Karthik Rao, M.D., as its Chief Medical Officer after serving in an interim role since February 2024. Dr. Rao brings significant experience in value-based care and will co-lead clinical strategy alongside Chief Clinical Officer Kevin Spencer, M.D. This leadership change aims to further empower physicians and improve care for Medicare patients.
Read more →-AGL
Jul 5, 2024Q&A with Dr. Joseph Allen: Getting Back to the Heart of Primary Care
Dr. Joseph Allen discusses the importance of primary care in the healthcare system and critiques the current hospital-centered model. He highlights the benefits of the agilon health Total Care Model, which allows for more personalized patient care and better outcomes. Allen believes this approach can attract younger physicians and improve the overall quality of primary care.
Read more →-AGL
Jun 5, 2024▲ +10.3%on this news
agilon health Names Jeff Schwaneke New Chief Financial Officer
Agilon Health has appointed Jeff Schwaneke as its new Chief Financial Officer, effective July 1, 2024. Schwaneke, who has over 27 years of experience in finance and managed care, succeeds Timothy Bensley, who is retiring. His role will involve overseeing the company's financial operations and contributing to strategic decisions.
Read more →-AGL
Jun 5, 2024▲ +10.3%on this newsshared move
agilon health Names Jeff Schwaneke New Chief Financial Officer AUSTIN, TX
Agilon health has appointed Jeff Schwaneke as its new Chief Financial Officer, effective July 1, 2024. Schwaneke, who has over 27 years of experience in finance and managed care, succeeds Timothy Bensley, who is retiring. In his new role, he will oversee the company's financial operations and will work closely with CEO Steve Sell and the Executive Leadership team. Schwaneke's appointment comes at a time of increased demand for agilon's healthcare model, reflecting the company's growth and strategic initiatives in the healthcare sector.
Read more →-AGL
May 7, 2024agilon health Announces New Physician Partnerships for 2025
Agilon health has announced new long-term partnerships with five physician practices across the U.S. to transition to a full-risk, value-based care model. This expansion will increase their Physician Network to over 3,000 primary care physicians serving more than 700,000 senior patients. The partnerships will enhance care delivery in communities including Kentucky, Minnesota, and North Carolina.
Read more →-AGL
May 7, 2024agilon health Reports First Quarter 2024 Results Revenue increased 52% to $1.6 billion, Medicare Advantage membership increased 43% to 523,000, and total members on the agilon platform grew to 654,000 Continued progress
Agilon Health (NYSE: AGL) reported positive first quarter 2024 results, with revenue reaching $1.6 billion, a 52% increase year-over-year, and a 43% rise in Medicare Advantage membership to 523,000. The company's performance action plan continues to drive operational improvements, although it also faced a net loss of $6 million for the quarter. Looking ahead, Agilon maintains its fiscal year 2024 guidance, focusing on enhancing profitability and expanding its member base through new partnerships.
Read more →-AGL
Feb 27, 2024▲ +5%on this news
agilon health Reports Fourth Quarter 2023 Results Revenue increased 72% to $1.06 billion in the fourth quarter 2023, Medicare Advantage membership increased 68% to 388,400, and total members on the agilon platform grew t
Agilon Health reported significant growth in revenue and membership for the fourth quarter of 2023, with total revenue rising 72% to $1.06 billion and Medicare Advantage membership increasing by 68%. However, the company faces substantial challenges, including a net loss of $230 million in Q4 and escalating medical costs impacting profitability. In light of these financial pressures, Agilon has outlined a targeted action plan aimed at enhancing performance and is optimistic about the future growth of its Medicare Advantage membership, projecting an increase to between 540,000 and 550,000 members by the end of 2024.
Read more →-AGL
Feb 8, 2024agilon health Announces Chief Medical Officer Transition
Agilon Health announced a transition in leadership as Dr. Benjamin Kornitzer steps down as Chief Medical Officer, effective March 1, 2024. He will take on a strategic advisory role while Dr. Karthik Rao serves as interim CMO. The company is actively searching for a new CMO to continue its clinical strategy.
Read more →-AGL
Feb 8, 2024▲ +8.2%on this newsshared move
agilon health Announces Chief Medical Officer Transition AUSTIN, T.X.
Agilon Health announced the transition of Dr. Benjamin Kornitzer from his role as Chief Medical Officer to a special advisor position effective March 1, 2024. In the interim, Dr. Karthik Rao, the senior medical director, will take over CMO responsibilities while agilon begins the search for a permanent replacement. The leadership change highlights agilon's commitment to advancing its clinical strategy as it continues to empower physician partnerships and transition to value-based care models.
Read more →-AGL
Feb 7, 2024▲ +10.6%on this news· ran to +26% by day 3shared move
Reducing Senior Patients’ Hospital Readmissions
The article discusses the importance of reducing hospital readmissions among senior patients, highlighting strategies such as identifying high-risk individuals, enhancing care coordination, and improving medication management. It emphasizes the role of the agilon Total Care Model in facilitating these efforts. Effective communication and proactive care are crucial for improving patient outcomes and reducing healthcare costs.
Read more →-AGL
Jan 5, 2024▼ -28.6%on this news
agilon health Announces Tim Bensley to Retire as CFO
Agilon health announced the retirement of CFO Timothy Bensley, expected within nine months. The company has begun the search for a new CFO, with Bensley remaining in his role during the transition. CEO Steve Sell expressed gratitude for Bensley's leadership over the past three years, highlighting his contributions to the company's growth.
Read more →-AGL
Jan 5, 2024▼ -28.6%on this newsshared move
agilon health Announces Tim Bensley to Retire as CFO AUSTIN, TX, JANUARY 5, 2024 - agilon health, Inc. (NYSE AGL), the trusted partner empowering physicians to transform health care in our communities, today announced th
Agilon Health, Inc. (NYSE: AGL) announced that Timothy Bensley will retire as CFO within the next nine months. Bensley will remain as CFO during the transition period and will serve in a consulting role afterward. The company expressed gratitude for his leadership over the past three years, especially noting his contributions during the firm's transition to becoming publicly traded in 2021. Agilon is actively searching for a successor to ensure continuity in its financial leadership.
Read more →-AGL
Jan 5, 2024▼ -28.6%on this newsshared move
agilon health Provides 2023 Guidance Update, Initial 2024 View Revised 2023 expectations and early outlook for 2024 reflect higher medical and non-medical costs Company is taking targeted actions to improve visibility, b
Agilon Health revised its 2023 financial guidance downward, citing higher-than-expected medical and non-medical costs, including increases in specialist visits and outpatient surgeries. The company anticipates a medical margin of $340 million to $360 million for 2023, which is approximately $110 million less than earlier forecasts. Despite this setback, Agilon has outlined initiatives aimed at improving financial predictability and optimizing operational performance in 2024. The firm also provided a positive initial outlook for 2024, projecting growth in members and Adjusted EBITDA.
Read more →-AGL
Jan 2, 2024Empowered PCP: The Power of agilon’s Physician Network
The article discusses the transformative impact of agilon health's physician network on primary care practices. Dr. Cindi Swaim shares her experiences, highlighting successful initiatives such as a medical assistant school and a congestive heart failure clinic. The network fosters collaboration, allowing physicians to share best practices and improve patient care, ultimately benefiting their communities.
Read more →-AGL
Dec 4, 2023Identifying High-Risk Patients in Value-Based Care
The article discusses the importance of identifying high-risk senior patients within value-based care models. It emphasizes that early identification can lead to better health outcomes and reduced healthcare costs. Utilizing data-driven strategies, healthcare providers can proactively manage patient care, ultimately preventing complications and hospital readmissions. Agilon health's Total Care Model is highlighted as a tool for effective risk identification.
Read more →-AGL
Nov 16, 2023▼ -5.1%on this news
Peer-Reviewed Study Finds Palliative Care Program Under agilon health’s Value-Based Model Significantly Improved Patient Outcomes
A recent peer-reviewed study published in the Journal of Pain and Symptom Management highlights the effectiveness of agilon health's integrated palliative care program. The study found that patients in this program experienced better outcomes, such as spending more time at home and fewer hospitalizations. The findings suggest that primary care physicians can significantly improve care for seriously ill patients under a value-based model.
Read more →-AGL
Nov 15, 2023How to Improve Post-Discharge Follow-up Care for Patients
The article discusses the importance of post-discharge follow-up care for senior patients, emphasizing strategies to enhance patient engagement. It highlights agilon health's Total Care Model, which fosters communication, personalized care plans, and patient education. The model aims to improve health outcomes and patient satisfaction, showcasing successful case studies and the significance of effective follow-up care.
Read more →-AGL
Nov 2, 2023agilon health Reports Third Quarter 2023 Results Revenue increased 75% to $1.22 billion, Medicare Advantage membership increased 58% to 420,300, and total members live on the agilon platform grew to 508,000 Strong perfor
Agilon Health reported a strong performance for Q3 2023, with revenues increasing by 75% to $1.22 billion and Medicare Advantage membership growing by 58% to reach 420,300 members. The company's total members on its platform also saw a significant increase to 508,000. The recent sale of MDX Hawaii will enable agilon to concentrate on its core partner markets, potentially enhancing its focus and operational efficiency moving forward. However, the company continues to face challenges with a net loss of $31 million and an Adjusted EBITDA loss of $6 million.
Read more →-AGL
Nov 1, 2023agilon health Announces Sale of MDX Hawaii
Agilon health has sold its subsidiary MDX Hawaii to a private buyer, allowing the company to concentrate on its core markets in the continental U.S. This strategic move is expected to enhance the focus on value-based care for senior patients. The transaction closed on October 31, with details to be discussed in the upcoming earnings call.
Read more →-AGL
Oct 23, 2023agilon health Reports ACO REACH Model Results for 2022 Performance Year
Agilon Health reported significant achievements in its ACO REACH model for the 2022 performance year, realizing $107 million in gross savings, including $24 million for the Medicare Trust Fund. The ACOs also attained a remarkable quality score of 99.8%, with most ACOs achieving perfect scores. The model emphasizes accountability among primary care physicians for patient health costs and quality.
Read more →-AGL
Oct 2, 2023Empowered PCP: Dr. Michael Morris on Improving Outcomes for High-Risk Senior Patients Using the agilon Total Care Model
Dr. Michael Morris discusses the challenges of treating high-risk senior patients and how the agilon Total Care Model addresses these issues. By focusing on value-based care, his clinic has improved patient outcomes and reduced healthcare costs. The model emphasizes comprehensive care, proactive management, and the importance of follow-up, ultimately fostering stronger doctor-patient relationships.
Read more →-AGL
Sep 25, 2023How Time Impacts the Patient-Physician Relationship
The article discusses the importance of time in the patient-physician relationship, highlighting how the traditional fee-for-service model often leads to rushed appointments. It emphasizes the benefits of value-based care, which allows physicians to spend more quality time with patients, improving health outcomes and patient satisfaction. The agilon Total Care Model is presented as a solution to enhance care quality and communication.
Read more →-AGL
Aug 28, 2023Health Care Flexibility with Value-Based Care
The article discusses the transformative impact of value-based care on healthcare delivery, particularly for senior patients with chronic conditions. It highlights how this model empowers physicians by providing flexibility and reducing administrative burdens, allowing for more personalized and effective treatment. Agilon's Total Care Model is emphasized as a key player in supporting this shift towards patient-centric care, aiming to improve outcomes through data-driven insights and collaborative care teams.
Read more →-AGL
Aug 3, 2023agilon health Reports Second Quarter 2023 Results Revenue increased 71% to $1.15 billion, Medicare Advantage membership increased 57% to 408,900, and total members live on the agilon platform grew to 495,900 Durability o
Agilon Health reported strong financial results for Q2 2023, with revenue increasing by 71% to $1.15 billion and Medicare Advantage membership rising by 57%. The company's growth is attributed to the durability of its partnership model. Despite a net loss of $17 million, there was an improvement compared to the previous year. The company also updated its outlook for FY 2023, anticipating further growth in revenue and member count.
Read more →-AGL
Jul 27, 2023Empowered PCP: Dr. John Notaro on the Importance of Palliative Care and Leveraging Specialists in VBC
Dr. John Notaro discusses the transformative impact of value-based care (VBC) on palliative care at Buffalo Medical Group. His partnership with agilon health has facilitated the establishment of an extensivist clinic, enhancing care delivery for senior patients. The integration of specialists into the VBC model has improved efficiency and patient outcomes, allowing for better management of complex health issues.
Read more →-AGL
Jun 26, 2023agilon health Names Silvana Battaglia to Board of Directors Longtime Human Resources Executive Brings Significant Business Leadership Experience to Role as Independent Member of agilon's Board Austin, TX
Agilon health, inc. has appointed Silvana Battaglia as an independent member of its Board of Directors. With over 20 years of experience in global human resources, Battaglia is expected to contribute significantly to the company's mission of transforming healthcare delivery. Ron Williams, Chairman of the Board, expressed confidence in her ability to shape a positive organizational culture and drive initiatives towards sustainable primary care. Battaglia currently serves as the Chief Human Resources Officer at AmerisourceBergen.
Read more →-AGL
May 9, 2023agilon health Reports First Quarter 2023 Results Revenue increased 74% to $1.14 billion and Medicare Advantage membership increased 61% to 402,200 Total members live on the agilon platform grew to 490,900, including 402,
Agilon Health reported a strong performance for the first quarter of 2023, achieving a revenue increase of 74% to $1.14 billion. The company also saw a substantial rise in Medicare Advantage membership, which grew by 61% to 402,200 members. Net income for the quarter was reported at $16 million, up from just $1 million in the same period last year. With new partnerships formed and positive growth metrics, Agilon Health is poised to enhance its services and market presence moving forward.
Read more →-AGL
Mar 1, 2023agilon health Reports Fourth Quarter and Fiscal Year 2022 Results Revenue increased 49% to $690 million, Medicare Advantage membership increased 45% to 269,500, and Medical Margin increased 93% to $61 million during the
Agilon Health has reported robust financial results for the fourth quarter and full fiscal year 2022, highlighting a 49% increase in revenue to $690 million and a significant rise in Medicare Advantage membership. The company also noted a remarkable 93% increase in the medical margin during the fourth quarter. Despite these gains, Agilon experienced a net loss of $57 million in Q4 2022, consistent with the previous year's results. The acquisition of mphrX is expected to further enhance their service efficiency moving forward.
Read more →-AGL
Nov 3, 2022agilon health Reports Third Quarter 2022 Results Revenue increased 52% to $695 million, Medicare Advantage membership increased 45% to 266,600, and Medical Margin increased 74% to $76 million Total members live on the ag
agilon health Reports Third Quarter 2022 Results Revenue increased 52% to $695 million, Medicare Advantage membership increased 45% to 266,600, and Medical Margin increased 74% to $76 million Total members live on the agilon platform grew to 356,000, including 266,600 Medicare
Read more →-AGL
Aug 4, 2022agilon health Reports Second Quarter 2022 Results Revenue increased 45% and Medicare Advantage membership grew 44% year-to-date Total members live on the agilon platform grew to 351,700, including 261,200 Medicare Advant
agilon health Reports Second Quarter 2022 Results Revenue increased 45% and Medicare Advantage membership grew 44% year-to-date Total members live on the agilon platform grew to 351,700, including 261,200 Medicare Advantage members and 90,500 Direct Contracting beneficiaries M
Read more →-AGL
May 5, 2022▼ -6.9%on this news· ran to -19% by day 3
agilon health Reports First Quarter 2022 Results Revenue growth of 58%, driven by 51% growth in Medicare Advantage membership Total members live on the agilon platform grew to 342,000, including 250,000 Medicare Advantag
agilon health Reports First Quarter 2022 Results Revenue growth of 58%, driven by 51% growth in Medicare Advantage membership Total members live on the agilon platform grew to 342,000, including 250,000 Medicare Advantage members and 92,000 Direct Contracting beneficiaries Med
Read more →-AGL
Mar 3, 2022agilon health Reports Fourth Quarter and Fiscal Year 2021 Results Revenue growth of 44% for the fourth quarter and 50% for fiscal year 2021 Total members live on the agilon platform grew 82% to 238,000, driven by 42% gro
agilon health Reports Fourth Quarter and Fiscal Year 2021 Results Revenue growth of 44% for the fourth quarter and 50% for fiscal year 2021 Total members live on the agilon platform grew 82% to 238,000, driven by 42% growth in Medicare Advantage and contribution from Direct Con
Read more →-AGL
Oct 28, 2021agilon health Reports Third Quarter 2021 Results Revenue growth of 47%, driven by 43% growth in Medicare Advantage membership Total membership growth of 83%, including Medicare Advantage and Direct Contracting Raised 202
agilon health Reports Third Quarter 2021 Results Revenue growth of 47%, driven by 43% growth in Medicare Advantage membership Total membership growth of 83%, including Medicare Advantage and Direct Contracting Raised 2021 guidance for membership, revenue, and Adjusted EBITDA
Read more →-AGL
Aug 4, 2021agilon health Reports Second Quarter 2021 Results LONG BEACH, Calif. –
agilon health Reports Second Quarter 2021 Results LONG BEACH, Calif. August 4, 2021 agilon health, inc. (NYSE: AGL), the company transforming health care for seniors by empowering primary-care physicians to focus on the entire health of their patients, announced results for the
Read more →-AGL
Jul 12, 2021agilon health Names Karen McLoughlin to its Board of Directors LONG BEACH, Calif. –
agilon health Names Karen McLoughlin to its Board of Directors LONG BEACH, Calif. July 12, 2021 agilon health, inc. (NYSE: AGL), the company transforming health care for seniors by empowering primary-care physicians to focus on the entire health of their patients, has named Kare
Read more →-AGL
May 26, 2021agilon health Reports First Quarter 2021 Results
agilon health Reports First Quarter 2021 Results LONG BEACH, Calif. - May 26, 2021 - agilon health, inc. (NYSE: AGL), the company transforming health care for seniors by empowering primary-care physicians to focus on the entire health of their patients, announced results for the
Read more →-AGL
Apr 19, 2021agilon health Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares
agilon health Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares LONG BEACH, Calif. April 19, 2021 agilon health, inc. (NYSE: AGL), which partners with primary care physicians to unlock value-based healthcare deli
Read more →Competitive Position
How AGL ranks across every disease it competes inCompetitive Position is a premium feature
See how AGL ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial